Heimo Haikala

1.8k total citations
26 papers, 1.5k citations indexed

About

Heimo Haikala is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Heimo Haikala has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cardiology and Cardiovascular Medicine and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Heimo Haikala's work include Heart Failure Treatment and Management (8 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Cardiac pacing and defibrillation studies (5 papers). Heimo Haikala is often cited by papers focused on Heart Failure Treatment and Management (8 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Cardiac pacing and defibrillation studies (5 papers). Heimo Haikala collaborates with scholars based in Finland, Hungary and United Kingdom. Heimo Haikala's co-authors include Jouko Levijoki, Inge‐Britt Lindén, Piero Pollesello, Petri Kaheinen, Erkki Nissinen, Zoltán Papp, István Édes, Richard J. Paul, Liisa Ahtee and Ove Eriksson and has published in prestigious journals such as Brain Research, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Heimo Haikala

26 papers receiving 1.4k citations

Peers

Heimo Haikala
W T Manders United States
Kevin J. Alker United States
David W. Amory United States
James Scheuer United States
J. B. Martins United States
SM Cobbe United Kingdom
Dirk Böcker Germany
S. H. Nellis United States
S L Hale United States
Heimo Haikala
Citations per year, relative to Heimo Haikala Heimo Haikala (= 1×) peers Hirokazu Hayakawa

Countries citing papers authored by Heimo Haikala

Since Specialization
Citations

This map shows the geographic impact of Heimo Haikala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heimo Haikala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heimo Haikala more than expected).

Fields of papers citing papers by Heimo Haikala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heimo Haikala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heimo Haikala. The network helps show where Heimo Haikala may publish in the future.

Co-authorship network of co-authors of Heimo Haikala

This figure shows the co-authorship network connecting the top 25 collaborators of Heimo Haikala. A scholar is included among the top collaborators of Heimo Haikala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heimo Haikala. Heimo Haikala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagy, László, Piero Pollesello, Heimo Haikala, et al.. (2016). ORM-3819 promotes cardiac contractility through Ca2+ sensitization in combination with selective PDE III inhibition, a novel approach to inotropy. European Journal of Pharmacology. 775. 120–129. 4 indexed citations
2.
Kankaanranta, Hannu, et al.. (2007). Antieosinophilic Activity of Simendans. Journal of Pharmacology and Experimental Therapeutics. 323(1). 31–38. 13 indexed citations
3.
Kaheinen, Petri, Piero Pollesello, Attila Borbély, et al.. (2006). Positive Inotropic Effect of Levosimendan is Correlated to its Stereoselective Ca2+‐Sensitizing Effect but not to Stereoselective Phosphodiesterase Inhibition. Basic & Clinical Pharmacology & Toxicology. 98(1). 74–78. 20 indexed citations
4.
Papp, Zoltán, et al.. (2005). Pharmacological Mechanisms Contributing to the Clinical Efficacy of Levosimendan. Cardiovascular Drug Reviews. 23(1). 71–98. 88 indexed citations
5.
Pollesello, Piero, Jouko Levijoki, Heimo Haikala, et al.. (2005). Two Inotropes With Different Mechanisms of Action: Contractile, PDE-Inhibitory and Direct Myofibrillar Effects of Levosimendan and Enoximone. Journal of Cardiovascular Pharmacology. 46(3). 369–376. 37 indexed citations
6.
Eriksson, Ove, Piero Pollesello, & Heimo Haikala. (2004). Effect of Levosimendan on Balance between ATP Production and Consumption in Isolated Perfused Guinea-Pig Heart before Ischemia or after Reperfusion. Journal of Cardiovascular Pharmacology. 44(3). 316–321. 28 indexed citations
7.
Pollesello, Piero, Jouko Levijoki, Petri Kaheinen, et al.. (2004). The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig. European Journal of Pharmacology. 486(1). 67–74. 96 indexed citations
8.
Kaheinen, Petri, Piero Pollesello, Jouko Levijoki, & Heimo Haikala. (2004). Effects of Levosimendan and Milrinone on Oxygen Consumption in Isolated Guinea-Pig Heart. Journal of Cardiovascular Pharmacology. 43(4). 555–561. 68 indexed citations
9.
Kaheinen, Petri, Piero Pollesello, Jouko Levijoki, & Heimo Haikala. (2001). Levosimendan Increases Diastolic Coronary Flow in Isolated Guinea-Pig Heart by Opening ATP-Sensitive Potassium Channels. Journal of Cardiovascular Pharmacology. 37(4). 367–374. 129 indexed citations
10.
Levijoki, Jouko, Piero Pollesello, Petri Kaheinen, & Heimo Haikala. (2001). Improved survival with simendan after experimental myocardial infarction in rats. European Journal of Pharmacology. 419(2-3). 243–248. 39 indexed citations
11.
Levijoki, Jouko, Piero Pollesello, Juha Kaivola, et al.. (2000). Further Evidence for the Cardiac Troponin C Mediated Calcium Sensitization by Levosimendan: Structure-response and Binding Analysis with Analogs of Levosimendan. Journal of Molecular and Cellular Cardiology. 32(3). 479–491. 63 indexed citations
12.
Haikala, Heimo, et al.. (1999). Levosimendan, a Calcium Sensitizer in Cardiac Muscle, Induces Relaxation in Coronary Smooth Muscle Through Calcium Desensitization. Journal of Pharmacology and Experimental Therapeutics. 288(1). 316–325. 84 indexed citations
13.
Haikala, Heimo, et al.. (1995). Troponin C–Mediated Calcium Sensitization Induced by Levosimendan Does Not Impair Relaxation. Journal of Cardiovascular Pharmacology. 25(5). 794–801. 187 indexed citations
14.
Haikala, Heimo, et al.. (1995). Troponin C-mediated calcium sensitization by levosimendan accelarates the proportional development of isometric tension. Journal of Molecular and Cellular Cardiology. 27(10). 2155–2165. 55 indexed citations
15.
Raasmaja, Atso, A. Talo, Heimo Haikala, et al.. (1992). Biochemical Properties of OR-1259 - A Positive Inotropic and Vasodilatory Compound with an Antiarrhythmic Effect. Advances in experimental medicine and biology. 311. 423–423. 11 indexed citations
16.
Haikala, Heimo, et al.. (1989). Nicotine antagonizes the effects of reserpine on the striatal metabolism of dopamine, 5-hydroxytryptamine and noradrenaline in hypothermic but not in normothermic mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 339(5). 546–550. 2 indexed citations
17.
Hukki, Jyri, Martti Attila, Heimo Haikala, et al.. (1989). Sequential changes of noradrenaline content of vein grafts in rats: Quantitative estimation by high‐performance liquid chromatography using electrochemical detection. Microsurgery. 10(2). 110–112. 2 indexed citations
18.
Haikala, Heimo. (1989). Dual Effects of Nicotine on Neuroleptic‐Induced Changes of Striatal Dopamine Metabolism in Mice. Pharmacology & Toxicology. 64(4). 334–339. 1 indexed citations
19.
Haikala, Heimo & Liisa Ahtee. (1988). Antagonism of the nicotine-induced changes of the striatal dopamine metabolism in mice by mecamylamine and pempidine. Naunyn-Schmiedeberg s Archives of Pharmacology. 338(2). 169–73. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026